Extract from M&A Insights

The below story was originally featured in our daily M&A Insights Newsletter. Selected stories, including this one, are posted to our website with some weeks of delay.
Vicore Pharma and HealthCap acquires INIM Pharma
July 5, 2018

Vicore Pharma Holding AB has entered into an agreement to acquire INIM Pharma AB, a Swedish biopharmaceutical company developing a new local treatment for severe rare lung diseases such as idiopathic pulmonary fibrosis. Payment for the acquisition is effectuated through an issue in kind, corresponding to a dilution of 35.8 percent. The Board of Directors of Vicore has decided to propose a rights issue of approximately SEK 80 million.

ⓘ This story was originally featured in our daily M&A Insights newsletter.
Our insights have been covered by: